Literature DB >> 12395030

Outpatient patterns of care and longitudinal intensity of antiretroviral therapy for HIV-infected drug users.

Christine Laine1, Walter W Hauck, Barbara J Turner.   

Abstract

OBJECTIVE: To examine the association of drug users' outpatient patterns of care with subsequent intensity of antiretroviral therapy (ART).
MATERIALS AND METHODS: Annual types of ART in 8897 New York State Medicaid drug users who were prescribed ART for > or =6 months in 1996 or 1997 were determined. From pharmacy claims, intensity was classified from changes in annual type of ART in 1996 to 97 and 1997 to 98 as: optimal (ie, on or starting highly active ART [HAART]), acceptable (ie, on or starting 2+ non-HAART drugs), or suboptimal (ie, none, <6 months, one drug, or change from HAART to non-HAART). In both 1996 and 1997, outpatient pattern of care was defined including regular medical care, regular drug treatment, both, and neither and categories of visits for HIV-focused care. Predictors of adequate ART intensity were examined among the group with suboptimal or adequate intensity (model 1) and predictors of optimal ART intensity among the group with adequate or optimal intensity (model 2).
RESULTS: The adjusted odds ratios (AOR) of acceptable ART intensity in model 1 were increased for those with HIV-focused care (AOR, 2.9; 95% CI, 2.6, 3.3 for 4+ visits 1.7; 95% CI, 1.5, 1.9 for 1-3 visits) or regular medical care (AOR, 1.2 [1.1, 1.4]. Adjusted odds ratios (AOR) of optimal intensity in model 2 were increased for those with regular substance abuse care with (AOR, 1.4 [1.2, 1.7]) or without (AOR, 1.2 [1.1, 1.4]) regular medical care whereas HIV-focused visits had no effect.
CONCLUSION: Care from an HIV-focused provider was predictive of a drug user receiving at least adequate intensity of ART for more than 2 years whereas regular drug abuse treatment, especially with regular medical care, was associated with optimal intensity of ART.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395030     DOI: 10.1097/00005650-200210000-00014

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  6 in total

Review 1.  HIV prevention among injection drug users: the need for integrated models.

Authors:  David S Metzger; Helen Navaline
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

2.  Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users.

Authors:  Barbara J Turner; Christine Laine; Leon Cosler; Walter W Hauck
Journal:  J Gen Intern Med       Date:  2003-04       Impact factor: 5.128

3.  Effect of dysthymia on receipt of HAART by minority HIV-infected women.

Authors:  Barbara J Turner; John A Fleishman
Journal:  J Gen Intern Med       Date:  2006-12       Impact factor: 5.128

Review 4.  The medical management of opioid dependence in HIV primary care settings.

Authors:  Paula J Lum; Jacqueline Peterson Tulsky
Journal:  Curr HIV/AIDS Rep       Date:  2006-11       Impact factor: 5.071

5.  Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999.

Authors:  Dawn K Smith; Lytt I Gardner; Ruby Phelps; Merle E Hamburger; Charles Carpenter; Robert S Klein; Ann Rompalo; Paula Schuman; Scott D Holmberg
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

6.  Utilization and costs of epidermal growth factor receptor mutation testing and targeted therapy in Medicare patients with metastatic lung adenocarcinoma.

Authors:  Chan Shen; Rolfy A Perez Holguin; Eric Schaefer; Shouhao Zhou; Chandra P Belani; Patrick C Ma; Michael F Reed
Journal:  BMC Health Serv Res       Date:  2022-04-09       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.